Khiron Life Sciences Corp. (KHRNF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 25, 2026
Khiron Life Sciences Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
Period Ending | Sep '22 Sep 30, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
| Cash & Equivalents | 1.94 | 8.92 | 21.65 | 9.17 | 14.93 | 1.81 |
| Short-Term Investments | - | - | - | 27.56 | 3.95 | - |
| Cash & Short-Term Investments | 1.94 | 8.92 | 21.65 | 36.73 | 18.88 | 1.81 |
| Cash Growth | -87.43% | -58.78% | -41.06% | 94.53% | 943.40% | - |
| Accounts Receivable | 4.38 | 2.88 | 4.58 | 3.15 | 2.92 | - |
| Other Receivables | 0.16 | - | - | 1.09 | 1.25 | 0.29 |
| Receivables | 4.54 | 2.88 | 4.58 | 4.24 | 4.17 | 0.29 |
| Inventory | 9.81 | 9.45 | 8.34 | 0.96 | 0.24 | - |
| Prepaid Expenses | 2.04 | 2.52 | 1.85 | 0.9 | 0.56 | 0.56 |
| Restricted Cash | - | - | - | 0.17 | 0.08 | - |
| Other Current Assets | - | - | - | 1.8 | - | - |
| Total Current Assets | 18.33 | 23.77 | 36.42 | 44.81 | 23.93 | 2.65 |
| Property, Plant & Equipment | 13.15 | 13.56 | 17.52 | 15.86 | 9.62 | 0.24 |
| Goodwill | 6.11 | 4.08 | 4.11 | 4.35 | 4.64 | - |
| Other Intangible Assets | 0.87 | 0.87 | 15.13 | 15.55 | 2.01 | 0 |
| Other Long-Term Assets | - | - | - | 1.34 | 0.15 | - |
| Total Assets | 38.45 | 42.27 | 73.18 | 81.91 | 40.35 | 2.9 |
| Accounts Payable | 6.76 | 4.31 | 6.26 | 7.43 | 6.44 | 0.45 |
| Accrued Expenses | - | - | - | - | - | 0.05 |
| Current Portion of Long-Term Debt | 0.47 | 0.74 | 0.5 | 0.57 | 0.16 | - |
| Current Portion of Leases | 0.76 | 0.79 | 0.58 | 0.44 | - | - |
| Other Current Liabilities | 1.08 | 1.89 | - | - | - | 0.21 |
| Total Current Liabilities | 9.06 | 7.72 | 7.34 | 8.44 | 6.6 | 0.7 |
| Long-Term Debt | 0.35 | - | - | - | 1.13 | - |
| Long-Term Leases | 0.99 | 0.71 | 1.71 | 2.55 | 1.22 | - |
| Long-Term Deferred Tax Liabilities | 0.26 | 0.31 | 0.9 | 0.89 | 0.65 | - |
| Other Long-Term Liabilities | 0.69 | 0.21 | - | - | 5.21 | - |
| Total Liabilities | 11.35 | 8.95 | 9.95 | 11.87 | 14.81 | 0.7 |
| Common Stock | 151.87 | 146.45 | 137.08 | 121.29 | 39.83 | 4.29 |
| Retained Earnings | -127.97 | -116.81 | -83.68 | -59.96 | -23.59 | -3.78 |
| Comprehensive Income & Other | 3.21 | 3.69 | 9.83 | 8.71 | 9.3 | 1.68 |
| Shareholders' Equity | 27.1 | 33.33 | 63.23 | 70.04 | 25.54 | 2.19 |
| Total Liabilities & Equity | 38.45 | 42.27 | 73.18 | 81.91 | 40.35 | 2.9 |
| Total Debt | 2.56 | 2.23 | 2.79 | 3.55 | 2.51 | - |
| Net Cash (Debt) | -0.63 | 6.7 | 18.86 | 33.18 | 16.37 | 1.81 |
| Net Cash Growth | - | -64.49% | -43.16% | 102.64% | 804.77% | - |
| Net Cash Per Share | -0.00 | 0.04 | 0.16 | 0.33 | 0.34 | 0.07 |
| Filing Date Shares Outstanding | 216.39 | 179.67 | 150.72 | 116.1 | 92.07 | 32.57 |
| Total Common Shares Outstanding | 217.14 | 179.26 | 150.72 | 116.61 | 75.04 | 32.57 |
| Working Capital | 9.27 | 16.06 | 29.07 | 36.37 | 17.34 | 1.95 |
| Book Value Per Share | 0.12 | 0.19 | 0.42 | 0.60 | 0.34 | 0.07 |
| Tangible Book Value | 20.12 | 28.39 | 43.98 | 50.14 | 18.9 | 2.19 |
| Tangible Book Value Per Share | 0.09 | 0.16 | 0.29 | 0.43 | 0.25 | 0.07 |
| Land | 1.28 | 1.09 | 1.31 | 1.38 | 1.47 | - |
| Buildings | 8.59 | 9.29 | 11.28 | 8.92 | 6.99 | - |
| Machinery | 5.19 | 4.38 | 4.02 | 3.4 | 0.98 | 0.03 |
| Construction In Progress | 1.01 | 0.95 | 0.84 | 0.81 | 0.51 | - |
| Leasehold Improvements | - | - | - | - | - | 0.21 |
Source: S&P Capital IQ. Standard template. Financial Sources.